Delivery Order SPE2DB22D2206-SPE2DB25FJC99
- Not listed
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Remicade 100 mg vials with a ceiling value of $14,097.07. This award is not set-aside and utilizes firm fixed-price pricing under a competitive delivery order contract. The performance location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.93 by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Remicade 100 mg vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is executed as a child contract under...
- AmerisourceBergen Drug Corp was awarded a $2,227.07 delivery order (Contract No. 4570103548) by the Defense Logistics Agency on November 25, 2025, for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract is scheduled for completion by November 26, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,146.30 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of November 17, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $17,733.06 from the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Remicade 100 mg vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $5,012.20 to supply 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,728.16 Firm Fixed Price Delivery Order is for the supply of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,155.03 for 100 mg vials of Remicade on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- This federal contract award, valued at $12,745.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Remicade 100 mg vials, a pharmaceutical product, with a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC99Delivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Remicade 100 mg vials, with a contract ceiling value of $27,685.64 and an ultimate completion date of July 30, 2025. This award is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The order represents a child contract action under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA for diverse pharmaceutical products spanning multiple therapeutic domains. Remicade, an immunosuppressant medication used primarily to treat inflammatory conditions, will be delivered to the Conshohocken, Pennsylvania facility. This delivery order award reflects AmerisourceBergen's ongoing role as a primary pharmaceutical supplier within the federal defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 7/29/25 |